Correlation Between Kilitch Drugs and Edelweiss Financial

Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Edelweiss Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Edelweiss Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kilitch Drugs Limited and Edelweiss Financial Services, you can compare the effects of market volatilities on Kilitch Drugs and Edelweiss Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Edelweiss Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Edelweiss Financial.

Diversification Opportunities for Kilitch Drugs and Edelweiss Financial

0.64

Correlation Coefficient

Kilitch Drugs  Edelweiss Financial

Poor diversification

The 3 months correlation between Kilitch and Edelweiss is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Edelweiss Financial Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edelweiss Financial and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Edelweiss Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edelweiss Financial has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Edelweiss Financial go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Edelweiss Financial

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to under-perform the Edelweiss Financial. But the stock apears to be less risky and, when comparing its historical volatility, Kilitch Drugs Limited is 1.4 times less risky than Edelweiss Financial. The stock trades about -0.01 of its potential returns per unit of risk. The Edelweiss Financial Services is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  7,626  in Edelweiss Financial Services on October 9, 2024 and sell it today you would earn a total of  4,931  from holding Edelweiss Financial Services or generate 64.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.18%
Values	Daily Returns

Kilitch Drugs Limited  vs.  Edelweiss Financial Services

Kilitch Drugs Limited

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Kilitch Drugs Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Edelweiss Financial

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Edelweiss Financial Services are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong forward indicators, Edelweiss Financial is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Kilitch Drugs and Edelweiss Financial

The main advantage of trading using opposite Kilitch Drugs and Edelweiss Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Edelweiss Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edelweiss Financial will offset losses from the drop in Edelweiss Financial's long position.

The idea behind Kilitch Drugs Limited and Edelweiss Financial Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.